Cargando…

Manganese Superoxide Dismutase Gene Polymorphism (V16A) is Associated with Diabetic Retinopathy in Slovene (Caucasians) Type 2 Diabetes Patients

Substantial data indicate that oxidative stress is involved in the development of diabetic retinopathy. Two candidate genes that affect the oxidative stress are manganese mitochondrial superoxide dismutase (Mn-SOD) and endothelial nitric oxide synthase (eNOS). The aim of the present study was to exa...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrovič, Mojca Globočnik, Cilenšek, Ines, Petrovič, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850621/
https://www.ncbi.nlm.nih.gov/pubmed/18057537
http://dx.doi.org/10.1155/2008/940703
_version_ 1782294129620811776
author Petrovič, Mojca Globočnik
Cilenšek, Ines
Petrovič, Daniel
author_facet Petrovič, Mojca Globočnik
Cilenšek, Ines
Petrovič, Daniel
author_sort Petrovič, Mojca Globočnik
collection PubMed
description Substantial data indicate that oxidative stress is involved in the development of diabetic retinopathy. Two candidate genes that affect the oxidative stress are manganese mitochondrial superoxide dismutase (Mn-SOD) and endothelial nitric oxide synthase (eNOS). The aim of the present study was to examine the role of the V16A polymorphism of the Mn-SOD gene and the 4a/b polymorphism of the eNOS gene in the development of diabetic retinopathy in Caucasians with type 2 diabetes. In this cross sectional case-control study 426 unrelated Slovene subjects (Caucasians) with type 2 diabetes mellitus were enrolled: 283 patients with diabetic retinopathy and the control group of 143 subjects with type 2 diabetes of duration of more than 10 years who had no clinical signs of diabetic retinopathy. A significantly higher frequency of the VV genotype of the V16A polymorphism of the Mn-SOD was found in patients with diabetic retinopathy compared to those without diabetic retinopathy (OR=2.1, 95% CI = 1.2–3.4; p = 0.006), whereas the 4a/b polymorphism of the eNOS gene failed to yield an association with diabetic retinopathy. We may conclude that the VV genotype of the V16A polymorphism of the Mn-SOD gene was associated with diabetic retinopathy in Caucasians with type 2 diabetes, therefore it might be used as a genetic marker of diabetic retinopathy in Caucasians.
format Online
Article
Text
id pubmed-3850621
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-38506212013-12-11 Manganese Superoxide Dismutase Gene Polymorphism (V16A) is Associated with Diabetic Retinopathy in Slovene (Caucasians) Type 2 Diabetes Patients Petrovič, Mojca Globočnik Cilenšek, Ines Petrovič, Daniel Dis Markers Other Substantial data indicate that oxidative stress is involved in the development of diabetic retinopathy. Two candidate genes that affect the oxidative stress are manganese mitochondrial superoxide dismutase (Mn-SOD) and endothelial nitric oxide synthase (eNOS). The aim of the present study was to examine the role of the V16A polymorphism of the Mn-SOD gene and the 4a/b polymorphism of the eNOS gene in the development of diabetic retinopathy in Caucasians with type 2 diabetes. In this cross sectional case-control study 426 unrelated Slovene subjects (Caucasians) with type 2 diabetes mellitus were enrolled: 283 patients with diabetic retinopathy and the control group of 143 subjects with type 2 diabetes of duration of more than 10 years who had no clinical signs of diabetic retinopathy. A significantly higher frequency of the VV genotype of the V16A polymorphism of the Mn-SOD was found in patients with diabetic retinopathy compared to those without diabetic retinopathy (OR=2.1, 95% CI = 1.2–3.4; p = 0.006), whereas the 4a/b polymorphism of the eNOS gene failed to yield an association with diabetic retinopathy. We may conclude that the VV genotype of the V16A polymorphism of the Mn-SOD gene was associated with diabetic retinopathy in Caucasians with type 2 diabetes, therefore it might be used as a genetic marker of diabetic retinopathy in Caucasians. IOS Press 2008 2007-11-26 /pmc/articles/PMC3850621/ /pubmed/18057537 http://dx.doi.org/10.1155/2008/940703 Text en Copyright © 2008 Hindawi Publishing Corporation.
spellingShingle Other
Petrovič, Mojca Globočnik
Cilenšek, Ines
Petrovič, Daniel
Manganese Superoxide Dismutase Gene Polymorphism (V16A) is Associated with Diabetic Retinopathy in Slovene (Caucasians) Type 2 Diabetes Patients
title Manganese Superoxide Dismutase Gene Polymorphism (V16A) is Associated with Diabetic Retinopathy in Slovene (Caucasians) Type 2 Diabetes Patients
title_full Manganese Superoxide Dismutase Gene Polymorphism (V16A) is Associated with Diabetic Retinopathy in Slovene (Caucasians) Type 2 Diabetes Patients
title_fullStr Manganese Superoxide Dismutase Gene Polymorphism (V16A) is Associated with Diabetic Retinopathy in Slovene (Caucasians) Type 2 Diabetes Patients
title_full_unstemmed Manganese Superoxide Dismutase Gene Polymorphism (V16A) is Associated with Diabetic Retinopathy in Slovene (Caucasians) Type 2 Diabetes Patients
title_short Manganese Superoxide Dismutase Gene Polymorphism (V16A) is Associated with Diabetic Retinopathy in Slovene (Caucasians) Type 2 Diabetes Patients
title_sort manganese superoxide dismutase gene polymorphism (v16a) is associated with diabetic retinopathy in slovene (caucasians) type 2 diabetes patients
topic Other
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850621/
https://www.ncbi.nlm.nih.gov/pubmed/18057537
http://dx.doi.org/10.1155/2008/940703
work_keys_str_mv AT petrovicmojcaglobocnik manganesesuperoxidedismutasegenepolymorphismv16aisassociatedwithdiabeticretinopathyinslovenecaucasianstype2diabetespatients
AT cilensekines manganesesuperoxidedismutasegenepolymorphismv16aisassociatedwithdiabeticretinopathyinslovenecaucasianstype2diabetespatients
AT petrovicdaniel manganesesuperoxidedismutasegenepolymorphismv16aisassociatedwithdiabeticretinopathyinslovenecaucasianstype2diabetespatients